India likely to approve two-dose regimen for Covid-19 vaccines, four weeks apart: Report1 min read . Updated: 03 Jan 2021, 08:34 AM IST
- Experts at India's Central Drugs Standards Control Organisation (CDSCO) have already approved the vaccines
- A final decision is expected to be announced by the agency's chief at a news conference scheduled today
NEW DELHI: India's drugs regulator is likely to approve administering two doses of the AstraZeneca/Oxford vaccine and another locally-developed one by Bharat Biotech, each four weeks apart, two sources with knowledge of the matter told Reuters on Saturday.
Select your Category